Accessibility Menu
Shandong Weigao Group Medical Polymer logo

Shandong Weigao Group Medical Polymer(SEHK) 1066

Market CapHK$14.75BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)+2,590%
5 Year-76%
1 Year-45%
1 Month-4%
HK$3.22
-2.13%
-0.07Today
Shandong Weigao Group Medical Polymer last closing stock price
MetricPriceDate
Last closeHKD 3.222026-08-31
Shandong Weigao Group Medical Polymer stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.4%HKD 3.442026-08-24
1 month-4.17%HKD 3.362026-07-31
3 month-5.57%HKD 3.412026-06-02
Year to date-35.86%HKD 5.022025-12-31
1 year-45.14%HKD 5.872025-08-29
3 year-58.72%HKD 7.802023-08-31
5 year-76.18%HKD 13.522021-09-01
Since inception+2,590.02%HKD 0.122004-02-27

Shandong Weigao Group Medical Polymer Financials at a Glance

Market Cap

HK$14.75BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥26.59B

Net Income (TTM)

CN¥3.33B

EPS (TTM)

HK$0.34

P/E Ratio

9.64

Dividend

HK$0.17

Beta (Volatility)

-0.03 (Low)

Price

HK$3.22

Volume

15,472,628

Open

HK$3.29

Previous Close

HK$3.29

Daily Range

HK$3.16 - HK$3.29

52-Week Range

HK$2.92 - HK$6.30

Estimated Earnings Date

Mar 30, 2027

1066 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shandong Weigao Group Medical Polymer

Shandong Weigao Group Medical Polymer Company Limited is a leading manufacturer of disposable medical devices based in Weihai, China. Established in 2000, the company specializes in the research, development, production, and distribution of a wide range of medical products, serving both domestic and international markets.

Products and Services
  • Disposable medical devices including infusion sets and syringes
  • Orthopedic and interventional products for surgical procedures
  • Pharmaceutical packaging and blood management solutions
Growth Outlook
  • Revenue of CNY 6.74 billion in Q4 2025, showing consistent growth
  • Net income increased to CNY 603.89 million in Q4 2025
  • Strong operating cash flow of CNY 1.73 billion in Q4 2025
Financial Highlights
  • TTM revenue of CNY 26.5 billion, reflecting robust demand
  • Net profit margin of 12.04% indicates effective cost management
  • Current ratio of 3.78 suggests strong liquidity position
Shandong Weigao Group Medical Polymer Company Limited operates in the medical instruments and supplies industry, focusing on high-quality disposable medical devices. The company has established a diverse product portfolio that includes essential healthcare items, catering to various medical needs. With a strong emphasis on research and development, Shandong Weigao continues to innovate and expand its offerings. The growth outlook for the company appears promising, as evidenced by the recent revenue figures and net income growth. The significant operating cash flow indicates a healthy financial position, allowing for potential reinvestment in further product development and market expansion. The financial highlights showcase a solid revenue base and effective cost management strategies, contributing to a favorable net profit margin. Overall, Shandong Weigao Group Medical Polymer Company Limited presents a compelling opportunity for investors interested in the healthcare sector, particularly in the growing market for disposable medical devices. The company's commitment to quality and innovation positions it well for future growth in both domestic and international markets.
AI Generated • Aug 11, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

13,307

CEO

Rinan Cong, MBA

Website

www.weigaogroup.com

Headquarters

Weihai, SD 264210, CN

1066 Financials

Key Financial Metrics (TTM)

Gross Margin

45.56%

Operating Margin

12.13%

Net Income Margin

10.13%

Return on Equity

5.64%

Return on Capital

5.64%

Return on Assets

3.85%

Earnings Yield

10.37%

Dividend Yield

5.32%

Payout Ratio

0.00%

Stock Overview

Market Cap

HK$14.75BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

4.49B

Volume

15.47M

Avg. Volume

21.87M

Financials (TTM)

Gross Profit

CN¥12.61B

Operating Income

CN¥3.82B

EBITDA

CN¥5.82B

Operating Cash Flow

CN¥5.40B

Capital Expenditure

-CN¥2.32B

Free Cash Flow

CN¥3.07B

Cash & ST Invst.

CN¥8.92B

Total Debt

CN¥4.96B

Shandong Weigao Group Medical Polymer Performance Analysis

Shandong Weigao Group Medical Polymer annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 15,986,636,6280.4%
20232023-12-31CNY 14,618,519,069-8.6%
20242024-12-31CNY 14,189,314,407-2.9%
20252025-12-31CNY 14,520,564,1132.3%
Shandong Weigao Group Medical Polymer sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-2.8%
Q22025-06-303.0%
Q42025-12-311.5%
Q22026-06-300.1%
Shandong Weigao Group Medical Polymer annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY 0.7117.0%
20232023-12-31CNY 0.49-31.1%
20242024-12-31CNY 0.490.6%
20252025-12-31CNY 0.38-21.9%
Shandong Weigao Group Medical Polymer sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-16.7%
Q22025-06-3010.0%
Q42025-12-31-40.9%
Q22026-06-3030.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CN¥6.75B

+1.8%

Gross Profit

CN¥3.13B

-7.4%

Gross Margin

46.29%

N/A

Market Cap

HK$14.75BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

HK$1.11M

N/A

Employees

13,307

N/A

Net Income

CN¥763.43M

-31.1%

EBITDA

CN¥1.62B

-4.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CN¥8.92B

+13.4%

Total Debt

CN¥4.96B

+20.0%

Accounts Receivable

CN¥8.56B

+7.5%

Inventory

CN¥2.54B

+10.1%

Long Term Debt

CN¥2.76B

-20.0%

Short Term Debt

CN¥2.19B

+225.4%

Return on Assets

3.85%

N/A

Return on Invested Capital

5.63%

N/A

Free Cash Flow

CN¥0.00

-100.0%

Operating Cash Flow

CN¥1.73B

+2.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About 1066

What is the current price of Shandong Weigao Group Medical Polymer?

Shandong Weigao Group Medical Polymer is trading at HK$3.22 per share.

What is the 52-week range for Shandong Weigao Group Medical Polymer?

Over the past 52 weeks, Shandong Weigao Group Medical Polymer has traded between HK$2.92 and HK$6.30.

How much debt does Shandong Weigao Group Medical Polymer have?

As of the most recent reporting period, Shandong Weigao Group Medical Polymer reported total debt of CN¥6.59B.

How much cash does Shandong Weigao Group Medical Polymer have on hand?

Shandong Weigao Group Medical Polymer reported CN¥10.01B in cash and cash equivalents in its most recent financial results.

What is Shandong Weigao Group Medical Polymer’s dividend yield?

Shandong Weigao Group Medical Polymer currently has a dividend yield of 5.32%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services